June 12, 2025
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Doris Stacy Gama
| Re: | Adial Pharmaceuticals, Inc. | ||
| Registration Statement on Form S-1 | |||
|
Filed June 6, 2025 File No: 333-287826 |
Dear Ms. Gama:
Reference is made to our letter, filed as correspondence via EDGAR on June 6, 2025, requesting acceleration of effectiveness of the above-referenced Registration Statement for Tuesday, June 10, 2025 at 9:00 a.m. Eastern Time, which was amended via telephone and email to Wednesday, June 12, 2025 at 5:00 p.m.
We are no longer requesting that such Registration Statement be declared effective at the time mentioned above, and we hereby formally withdraw our request for acceleration of the above referenced effective date.
| Very truly yours, | |||
| ADIAL PHARMACEUITCALS, INC. | |||
| By: | /s/ Cary Claiborne | ||
| Name: | Cary Claiborne | ||
| Title: | Chief Executive Officer | ||
cc: Leslie Marlow, Blank Rome LLP